Dear Colleagues
A warm invitation to JOIN US at #APCCCDiagnostics25
A HYBRID Meeting (In Person & Live) in Lugano Switzerland February 27-28, 2025

REGISTER: https://buff.ly/4eSVBsa

Enjoy Early Bird Registration, NOW OPEN
ONLINE REGISTRATION FOR LMIC's FREE‼️
OncoAlert 🚨Will be Livewith Coverage

JOIN US at #APCCCDiagnostics25 🇨🇭in Lugano

A HYBRID Meeting (In Person & Live) Switzerland

February 27-28, 2025 REGISTER: apccc.org/apccc-diagno...

ONLINE REGISTRATION FOR LMIC's FREE

@silkegillessen.bsky.social @aureliusomlin.bsky.social @barbaramelao.bsky.social @drnataliagandur.bsky.social

LIVE DAY TWO #APCCCDiagnostics25 in Lugano🇨🇭

Dr. Matthew Cooperberg @dr_coops 🇺🇸 discussing How do genomic classifiers contribute in the BCR situation?

In 2025, the most definitive role for biomarkers in post-operative BCR is using Decipher to guide the intensification of SRT w/ADT

LIVE DAY ONE #APCCCDiagnostics25 in Lugano🇨🇭

Dr. Jonas Hugosson🇸🇪 discussing
How do you (best evidenced) screen for prostate cancer?

MRI detects the vast majority of high-grade prostate cancers, but it also identifies 50% of ISUP Grade 1 cancers, especially larger ones

PET PSMA refining patients classification mCSPC #prostatecancer
But what to do with it? Need for clinical trials. #APCCCDiagnostics25 @OncoAlert

Amazing discussion this morning on imaging in the BCR setting of #prostatecancer
#APCCCDiagnostics25
#PSMAPET by Irene Burger

LIVE DAY TWO #APCCCDiagnostics25 in Lugano🇨🇭

Dr. Matthew Cooperberg @dr_coops 🇺🇸 discussing
How do genomic classifiers contribute in the
BCR situation?

In 2025, the most definitive role for biomarkers in post-operative BCR is using Decipher to guide the intensification of SRT w/ ADT

Amazing post-#APCCCDiagnostics25 ⛷️🚠🏂❄️🍴in Davos 🇨🇭
The best company in an enchanting location 🏔️
@silkegillessen.bsky.social @prof-nick-james.bsky.social @attardlab.bsky.social @aureliusomlin.bsky.social @apccc.bsky.social